M
Matinas BioPharma Holdings Inc
AMEX:MTNB
Matinas BioPharma Holdings Inc
AMEX:MTNB
Price:
0.5
USD
-0.97%
Market Closed
Market Cap:
$3.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Matinas BioPharma Holdings Inc
AMEX:MTNB
|
US |
|
T
|
Tessellis SpA
MIL:TSL
|
IT |
|
Rover Metals Corp
F:4XO0
|
CA |
|
B
|
Big Yellow Group PLC
OTC:BYLOF
|
UK |
|
Nexus Infrastructure PLC
LSE:NEXS
|
UK |
|
N
|
Nanjing Securities Co Ltd
SSE:601990
|
CN |
|
T
|
Tenmaya Store Co Ltd
TSE:9846
|
JP |
|
Catalent Inc
NYSE:CTLT
|
US |
|
Gautam Gems Ltd
BSE:540936
|
IN |
|
H
|
Hoang Huy Investment Services JSC
VN:HHS
|
VN |
|
A
|
Aveng Ltd
JSE:AEG
|
ZA |
|
Mapletree Pan Asia Commercial Trust
SGX:N2IU
|
SG |
|
CTEEP Companhia de Transmissao de Energia Eletrica Paulista
BOVESPA:TRPL4
|
BR |
|
Shenzhen Etmade Automatic Equipment Co Ltd
SZSE:300812
|
CN |
|
Moderna Inc
NASDAQ:MRNA
|
US |
|
M
|
Mdundocom A/S
CSE:MDUNDO
|
DK |
Income Statement
Earnings Waterfall
Matinas BioPharma Holdings Inc
Matinas BioPharma Holdings Inc
Income Statement
Matinas BioPharma Holdings Inc
Matinas BioPharma Holdings Inc
Currency: USD
| Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+65%
|
0
+21%
|
0
N/A
|
0
-50%
|
0
-65%
|
0
N/A
|
1
N/A
|
2
+100%
|
3
+50%
|
4
+34%
|
3
-25%
|
2
-33%
|
1
-49%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||||||||
| Operating Expenses |
0
|
0
|
(19)
|
(7)
|
(12)
|
(18)
|
(24)
|
(24)
|
(23)
|
(25)
|
(25)
|
(26)
|
(28)
|
(28)
|
(28)
|
(27)
|
(26)
|
(26)
|
(25)
|
(24)
|
(23)
|
(22)
|
(20)
|
(15)
|
(12)
|
(5)
|
|
| Selling, General & Administrative |
0
|
0
|
(8)
|
(2)
|
(5)
|
(7)
|
(10)
|
(11)
|
(11)
|
(11)
|
(10)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(11)
|
(11)
|
(10)
|
(10)
|
(10)
|
(9)
|
(9)
|
(6)
|
(5)
|
(5)
|
|
| Research & Development |
0
|
0
|
(11)
|
(4)
|
(7)
|
(11)
|
(14)
|
(10)
|
(9)
|
(10)
|
(15)
|
(16)
|
(18)
|
(17)
|
(17)
|
(16)
|
(15)
|
(15)
|
(14)
|
(14)
|
(14)
|
(13)
|
(11)
|
(5)
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(4)
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(7)
|
0
|
|
| Operating Income |
0
N/A
|
0
N/A
|
(19)
N/A
|
(7)
+61%
|
(12)
-65%
|
(18)
-46%
|
(24)
-37%
|
(24)
0%
|
(23)
+4%
|
(25)
-5%
|
(25)
-1%
|
(26)
-6%
|
(27)
-4%
|
(26)
+5%
|
(25)
+5%
|
(22)
+9%
|
(23)
-1%
|
(23)
-3%
|
(24)
-2%
|
(24)
+1%
|
(23)
+1%
|
(22)
+8%
|
(20)
+6%
|
(15)
+27%
|
(12)
+19%
|
(5)
+58%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
1
|
0
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(4)
|
(4)
|
|
| Pre-Tax Income |
0
N/A
|
0
N/A
|
(17)
N/A
|
(5)
+71%
|
(11)
-111%
|
(16)
-51%
|
(22)
-39%
|
(22)
+0%
|
(22)
+4%
|
(23)
-6%
|
(23)
-2%
|
(24)
-4%
|
(25)
-5%
|
(24)
+5%
|
(21)
+13%
|
(21)
+2%
|
(21)
-1%
|
(21)
-3%
|
(23)
-8%
|
(23)
-1%
|
(23)
+1%
|
(21)
+8%
|
(24)
-15%
|
(18)
+26%
|
(15)
+15%
|
(9)
+43%
|
|
| Net Income | |||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
0
|
0
|
(17)
|
(5)
|
(11)
|
(16)
|
(22)
|
(22)
|
(22)
|
(23)
|
(23)
|
(24)
|
(25)
|
(24)
|
(21)
|
(21)
|
(21)
|
(21)
|
(23)
|
(23)
|
(23)
|
(21)
|
(24)
|
(18)
|
(15)
|
(9)
|
|
| Net Income (Common) |
0
N/A
|
0
N/A
|
(18)
N/A
|
(5)
+71%
|
(11)
-111%
|
(17)
-52%
|
(23)
-39%
|
(23)
+0%
|
(22)
+3%
|
(24)
-5%
|
(24)
-1%
|
(24)
-3%
|
(25)
-4%
|
(24)
+5%
|
(21)
+13%
|
(21)
+2%
|
(21)
-1%
|
(21)
-3%
|
(23)
-8%
|
(23)
-1%
|
(23)
+1%
|
(21)
+8%
|
(24)
-15%
|
(18)
+26%
|
(15)
+15%
|
(9)
+43%
|
|
| EPS (Diluted) |
0
N/A
|
0
N/A
|
-0.13
N/A
|
-0.03
+77%
|
-0.06
-100%
|
-0.09
-50%
|
-0.12
-33%
|
-0.12
N/A
|
-0.11
+8%
|
-0.11
N/A
|
-5.63
-5 018%
|
-0.11
+98%
|
-0.12
-9%
|
-0.11
+8%
|
-4.84
-4 300%
|
-0.09
+98%
|
-0.1
-11%
|
-0.1
N/A
|
-5.28
-5 180%
|
-5.34
-1%
|
-4.59
+14%
|
-4.19
+9%
|
-4.98
-19%
|
-3.54
+29%
|
-2.79
+21%
|
-1.38
+51%
|
|
Switch to:
Switch to:
See Also
Discover More
